注册
CN
首页 > 产品中心 > 试剂盒 > ADA检测试剂盒
产品筛选+
选项
确认
  • 产品类别
    已选0项
    Antibodies (2)
    Assay Kit (303)
  • 靶标
    已选0项
    Simlukafusp Alfa (1)
    Suptavumab (2)
    Zenocutuzumab (2)
    Glycoprotein (4)
    Ranibizumab (4)
    Polatuzumab (1)
    Lodelcizumab (2)
    Gevokizumab (2)
    RBD (Delta) (2)
    Marstacimab (2)
    Varlilumab (2)
    Pembrolizumab (4)
    Faricimab (2)
    M1R (6)
    Emactuzumab (2)
    Zalifrelimab (2)
    Teclistamab (2)
    Dilpacimab (2)
    Lenzilumab (2)
    Casirivimab (1)
    Lorvotuzumab (2)
    Cusatuzumab (2)
    Secukinumab (3)
    Serclutamab (2)
    Tarextumab (1)
    Tocilizumab (4)
    Indatuximab (2)
    Lintuzumab (2)
    Amatuximab (2)
    Suvizumab (2)
    Clazakizumab (2)
    GP/Envelope glycoprotein (3)
    Varisacumab (2)
    Ivuxolimab (2)
    Tezepelumab (2)
    Basiliximab (2)
    Spike glycoprotein (10)
    Obinutuzumab (3)
    Talacotuzumab (2)
    Sintilimab (2)
    Nesvacumab (2)
    H3L (4)
    Cixutumumab (2)
    Edrecolomab (2)
    Pasotuxizumab (2)
    Navicixizumab (2)
    Namilumab (2)
    Imdevimab (1)
    Tisotumab (2)
    Vorsetuzumab (2)
    Tibulizumab (2)
    Tesidolumab (2)
    Eculizumab (3)
    Lacnotuzumab (2)
    Sacituzumab (2)
    Oleclumab (2)
    Anetumab (2)
    Foravirumab (2)
    Olokizumab (2)
    Tirzepatide (1)
    Crizanlizumab (2)
    Pogalizumab (2)
    Elezanumab (2)
    Camidanlumab (2)
    Spike Protein (Trimer) (2)
    Epcoritamab (2)
    Vibecotamab (2)
    Tislelizumab (2)
    Vanucizumab (2)
    E8L (6)
    Dalotuzumab (2)
    Rolinsatamab (2)
    Rosopatamab (3)
    Atezolizumab (4)
    Otilimab (2)
    F/Fusion glycoprotein F0 (3)
    Imalumab (2)
    Meplazumab (2)
    Vunakizumab (2)
    Tanezumab (2)
    Denosumab (3)
    Adalimumab (4)
    Cetuximab (3)
    Semorinemab (2)
    Zampilimab (2)
    Ontamalimab (2)
    Benufutamab (2)
    Rafivirumab (2)
    Sirukumab (2)
    Guselkumab (2)
    Inclacumab (2)
    Tavolimab (2)
    Enfortumab (2)
    Daclizumab (2)
    NP/Nucleocapsid (3)
    Glofitamab (2)
    Bimagrumab (2)
    Toripalimab (2)
    Lupartumab (2)
    A35R (6)
    Figitumumab (2)
    Anifrolumab (2)
    NOTCH2 (1)
    Avelumab (4)
    Milatuzumab (2)
    Elotuzumab (1)
    Andecaliximab (2)
    Alacizumab (2)
    Tiragolumab (3)
    Enoblituzumab (2)
    Certolizumab (3)
    Sarilumab (2)
    Tilavonemab (2)
    Vofatamab (2)
    Glembatumumab (2)
    Conatumumab (2)
    Tosatoxumab (2)
    Ziltivekimab (2)
    Romiplostim (1)
    Olaratumab (2)
    Lirilumab (2)
    Ianalumab (2)
    Ibalizumab (2)
    Etanercept (1)
    Ibritumomab (2)
    Daratumumab (4)
    Afasevikumab (2)
    Depatuxizumab (2)
    Ganitumab (2)
    Icrucumab (2)
    Urelumab (2)
    Durvalumab (4)
    Disitamab (2)
    Evolocumab (1)
    Farletuzumab (2)
    Ramucirumab (2)
    Ascrinvacumab (2)
    Mirzotamab (2)
    Golimumab (3)
    Ustekinumab (3)
    Zagotenemab (2)
    Oxelumab (2)
    Balstilimab (2)
    Drozitumab (2)
    Obiltoxaximab (2)
    Cergutuzumab (2)
    Tovetumab (2)
    Codrituzumab (2)
    Blosozumab (2)
    Tregalizumab (2)
    Rituximab (1)
    Mosunetuzumab (2)
    Ifabotuzumab (2)
    Bimekizumab (2)
    Losatuxizumab (2)
    Teprotumumab (2)
    Ieramilimab (2)
    Utomilumab (2)
    Pacmilimab (2)
    Pertuzumab (4)
    Alirocumab (1)
    Mirvetuximab (2)
    Bevacizumab (4)
    Cinpanemab (2)
    Omburtamab (2)
    Infliximab (3)
    Omalizumab (2)
    Befovacimab (2)
    Dupilumab (4)
    Cetrelimab (2)
    Lexatumumab (2)
    Gremubamab (2)
    Labetuzumab (2)
    Ipilimumab (3)
    Astegolimab (2)
    Romosozumab (2)
    Zanolimumab (2)
    Natalizumab (2)
    Ocaratuzumab (2)
    Letolizumab (2)
    Ixekizumab (2)
    Necitumumab (2)
    Afutuzumab (1)
    Apamistamab (2)
    Mavezelimab (2)
    Magrolimab (2)
    Nirsevimab (2)
    Trastuzumab (3)
    RBD (Omicron/BA.5) (3)
    Zanidatamab (2)
    dsDNA (1)
    Brolucizumab (2)
    Iladatuzumab (1)
    Frovocimab (2)
    Canakinumab (2)
    RBD (4)
    Concizumab (2)
    Iscalimab (2)
    Nivolumab (6)
    Tigatuzumab (2)
    A29L (6)
    Cabiralizumab (2)
    Tremelimumab (2)
    Belantamab (2)
    Mirikizumab (3)
    Eldelumab (2)
    Sotrovimab (1)
    Carlumab (2)
    Itolizumab (2)
    Remtolumab (2)
    Panitumumab (4)
    CD79B (2)
    Emibetuzumab (2)
    Favezelimab (2)
    Sibrotuzumab (2)
    Palivizumab (4)
  • 应用
    已选0项
    ELISA (494)
  • 种属反应性
    已选0项
    Nivolumab (2)
  • 宿主
    已选0项
    Rabbit (2)
  • 克隆类型
    已选0项
    Monoclonal (2)
  • 偶联物
    已选0项
    Unconjugated (2)
  • 品牌
    已选0项
    ProteoGenix (190)
    abinScience (305)

  • 7X24小时产品咨询热线：027--87433958(9:00-18:00)，或扫描下方产品专员二维码或在线留言

  • 武汉东湖新技术开发区神墩四路666号研发楼B区3层东

  • 24小时产品查询

  • 扫一扫关注我们

  • 专属渠道经理

Copyright © 2025 武汉艾必赛生物科技有限公司版权所有 所有产品仅可用于工业或者科研等非医疗目的。
鄂ICP备2023002448号-2